Prevalence of Gastric Motor Dysfunction and Upper GI Symptoms in Gastric Antral Vascular Ectasias

Description

The researchers are trying to find out more about Gastric Antral Vascular Ectasia (GAVE). This is a condition that affects the blood vessels in the stomach, leading to their enlargement and possible bleeding. It can also cause symptoms such as abdominal pain and nausea. By participating in this study, you will help us learn how often these symptoms occur and how they relate to stomach functioning.

Conditions

Gastric Antral Vascular Ectasia, Cirrhosis

Talk to us

Study Overview

On this page

Study Details

Study overview

The researchers are trying to find out more about Gastric Antral Vascular Ectasia (GAVE). This is a condition that affects the blood vessels in the stomach, leading to their enlargement and possible bleeding. It can also cause symptoms such as abdominal pain and nausea. By participating in this study, you will help us learn how often these symptoms occur and how they relate to stomach functioning.

Prevalence of Gastric Motor Dysfunction and Upper GI Symptoms in Gastric Antral Vascular Ectasias

Prevalence of Gastric Motor Dysfunction and Upper GI Symptoms in Gastric Antral Vascular Ectasias

Condition
Gastric Antral Vascular Ectasia
Intervention / Treatment

-

Contacts and Locations

Rochester

Mayo Clinic, Rochester, Minnesota, United States, 55905

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * Patients \>18 years of age with endoscopic evidence of Gastric Antral Vascular Ectasia.
  • * Willingness to participate in the study
  • * Capacity to provide informed consent.
  • * No evidence of organic, systemic, or metabolic disease (e.g. diabetes mellitus) to explain the symptoms on routine investigations
  • * Patients with active bleeding.
  • * Patients with severe decompensated liver disease.
  • * Patients with chronic kidney disease.
  • * Presence of other diseases (structural or metabolic) which could interfere with interpretation of the study results.
  • * Pregnant or lactating women due to radiation exposure.

Ages Eligible for Study

19 Years to

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

Mayo Clinic,

Xiao Jing Wang, MD, PRINCIPAL_INVESTIGATOR, Mayo Clinic

Study Record Dates

2026-09-01